1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES – TCTMD

February 7, 2012Immunosuppressive Drugsadmin

TCTMD

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES
TCTMD
By Yael L. Maxwell Newer-generation everolimus-eluting stents (EES) are associated with a lower risk of stent thrombosis—in particular very late stent thrombosis—compared with older sirolimus- and paclitaxel-eluting stents (SES and PES), according to ...

Post navigation

← National Heart Failure Awareness Week: February 12-18, 2012 – Sacramento Bee American Red Cross releases blood donation opportunities for February – Galesburg Register-Mail →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos